Trending Topic

6 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

The first-in-human implantation of a leadless pacing system occurred already more than 10 years ago.1 The first-generation ventricular leadless pacemaker could provide only asynchronous ventricular pacing (ventricular, ventricular, inhibited [VVI], or ventricular, ventricular, inhibited, rate response [VVIR]), limiting its indications to patients with atrial fibrillation and severe bradycardia, those precluded for implantation of a transvenous pacemaker […]

C Michael Gibson, C3 2019 – The Changing Landscape of Clinical Trials

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jul 5th 2019

Dr C Michael Gibson (Beth Israel Deaconess Medical Center, Boston, MA, USA) spoke to us at C3 2019 about his thoughts and experiences on clinical trials and how the landscape of clinical trials is changing.

Speaker’s Disclosures: C Michael Gibson wishes to declare relationships with Johnson + Johnson and Apple.

Questions:
1. Share your thoughts and experiences of clinical trials and how the landscape is changing (0:04)

touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.

Filmed in partnership with C3 at the 2019 annual meeting in Orlando, Florida, June 2019.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup